Form 4: NeueHealth Director Acquires Warrants in Recent Transaction

Sentiment:

SEC Form 4


Director Edward T. Mathers reports acquisition of warrants for NeueHealth, Inc.

Summary

  • On October 1, 2024, Edward T. Mathers, a director of NeueHealth, Inc., acquired warrants to purchase common stock.
  • The warrants have an exercise price of $0.01.
  • 61,865 warrants were acquired related to NEA 17, and 185,595 warrants were acquired related to NEA 18 VGE.
  • The warrants are exercisable from October 2, 2024, and expire on April 30, 2029.
  • Following the transaction, the reporting person indirectly holds 185,594 warrants through NEA 17 and 556,782 warrants through NEA 18 VGE.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating warrant acquisition, which could be seen as a positive sign of insider confidence, but doesn't provide enough information to strongly influence sentiment.

Positives

  • The acquisition of warrants by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to the market.

Stakeholder Impact

  • The warrant acquisition could have a minor positive impact on shareholder sentiment.

Key Dates

DateDescription
August 4, 2023Date of the Credit Agreement between the Issuer and the lenders thereto.
October 2, 2023Date of Incremental Amendment No. 1 to the Credit Agreement.
April 8, 2024Date of the Warrantholders Agreement and Incremental Amendment No. 2 to the Credit Agreement.
October 1, 2024Date of the warrant acquisition transaction.
October 2, 2024Date the warrants become exercisable.
April 30, 2029Expiration date of the warrants.
October 03, 2024Date of signature of the report.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.